OTC Markets Group Appoints Olivier Roguez as VP of Market Data for EMEA to Drive Regional Growth
By Lauren Towner · 9 November 2026
In brief: OTC Markets Group has appointed Olivier Roguez as VP of Market Data for EMEA to lead regional growth and expand data distribution for its 12,000 U.S. and international securities.
| European Cross-Traded Volume | $329.6 billion |
|---|---|
| Volume Growth | 29% year over year |
| Total International Volume | $618.9 billion |
| Securities Traded | 12,000 |

OTC Markets Group has appointed Olivier Roguez as Vice President of Market Data for the EMEA region, signaling a strategic push to capture growing demand for U.S. equity data in Europe. With European cross-traded volume reaching $329.6 billion this year, the move highlights the increasing importance of transatlantic liquidity for institutional investors and data distributors.
What was announced
OTC Markets Group, which operates regulated markets for 12,000 securities, has tasked Roguez with leading its market data growth strategy across Europe, the Middle East, and Africa. Based in London, he will focus on business development efforts spanning distributors and exchanges. The appointment comes at a time of significant activity for the firm in the region; through the end of the third quarter, European cross-traded dollar volume on OTC Markets reached $329.6 billion. This represents a 29% increase year-over-year and accounts for 50% of the $618.9 billion in total international cross-traded volume handled by the operator.
Roguez brings over two decades of experience to the role, having most recently worked at Cboe Labs in business and product development, where he led innovation across the EMEA region. His career includes a tenure as Regional Head of Business Development at Capitalab and a decade as Head of Sales EMEA at ICAP Information Services. He began his career in market data sales and vendor relations at Dow Jones Newswires. Reporting to Matthew Fuchs, EVP of Market Data, Roguez is expected to leverage this background to expand the firm’s distribution network and partnerships, catering to a growing desire within EMEA to understand U.S. investor behavior regarding cross-traded securities.
"OTC Markets offers a unique view into thousands of U.S. and international securities, and there is desire across EMEA to understand how U.S. investors trade these securities,"
Olivier Roguez
The companies involved
OTC Markets Group Inc. operates the OTCQX Best Market, the OTCQB Venture Market, and the Pink Open Market. Headquartered in New York and trading under the symbol OTCM, the company provides the financial infrastructure for a vast array of U.S. and global securities. Its primary function is to provide transparent trading and data services that allow companies to build visibility with American investors without the complexities of a traditional exchange listing. By providing market data and execution services, the group acts as a critical bridge between international issuers and the U.S. capital markets.
The firm has increasingly positioned itself as a global gateway, particularly for European firms seeking "cross-trading" capabilities—where shares are traded in the U.S. in dollars during American market hours. This infrastructure is supported by a network of broker-dealers and data redistributors that rely on OTC Markets' proprietary data feeds to provide price discovery and liquidity information to a global client base. The company currently oversees the trading of approximately 12,000 different securities on its regulated platforms.
What FF News has reported before
FF News has previously tracked OTC Markets Group’s efforts to modernize market infrastructure and integrate with emerging financial technologies. In July 2026, the publication reported on how OTC Markets and Elysium Bridge Gap Between Traditional Finance and Digital Asset Custodians. That initiative focused on connecting legacy financial systems with digital asset custody solutions, reflecting a broader trend of the firm expanding its reach beyond traditional equity trading. This prior coverage underscores the group's ongoing strategy to diversify its service offerings and strengthen its role as a data-centric intermediary in an evolving global regulatory landscape.
What this means
The appointment of a Cboe veteran to lead EMEA data strategy suggests that OTC Markets sees data, rather than just trading volume, as its primary growth engine in Europe. As European regulators continue to scrutinize market transparency and consolidated tapes, the demand for high-quality, cross-border equity data is intensifying. This move puts pressure on traditional regional exchanges that have historically dominated local data sales. The 29% jump in European volume indicates that the "global gateway" model is gaining traction, but the challenge remains in converting that volume into high-margin data subscriptions. The industry will be watching to see if this hire leads to deeper integrations with European retail platforms and institutional terminals.
Frequently asked questions
Who is the new VP of Market Data for EMEA at OTC Markets Group?
Olivier Roguez has been appointed as the Vice President of Market Data for EMEA. He joins from Cboe Global Markets – Europe and brings over 20 years of experience in market data sales and business development to lead OTC Markets' growth strategy in the region.
How much has European trading volume grown on OTC Markets?
Through the end of Q3, European cross-traded dollar volume on OTC Markets reached $329.6 billion. This represents a significant 29% increase year over year, with the EMEA region now accounting for 50% of the total international cross-traded volume.
What is the primary goal of OTC Markets' expansion in Europe?
The primary goal is to drive market data growth and educate European investors, issuers, and participants on using OTC Markets as a global gateway to the U.S. equity market. The company aims to expand its distribution network and partnerships across the EMEA region.
About the companies
Companies in this story: OTC Markets Group
People in this story: Matthew Fuchs, Olivier Roguez